echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Tianyu Pharmaceutical's API Proline Henggliflozin has been approved by CDE

    Tianyu Pharmaceutical's API Proline Henggliflozin has been approved by CDE

    • Last Update: 2022-01-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On the evening of January 5, Tianyu Pharmaceutical issued an announcement saying that the API of Proline Henggliflozin had recently passed the CDE technical review
    .

    Proline constagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, by inhibiting SGLT2, it reduces the reabsorption of glucose filtered by the renal tubules, thereby increasing urinary glucose excretion
    .

    In June 2020, Tianyu Pharmaceutical submitted a drug registration application for Proline Henggliflozin API to CDE and was accepted
    .

    According to the announcement on the CDE website, there is only one manufacturer of proline henggliflozin API that has passed the CDE technical review
    .


    The company's Proline Henggliflozin has completed the GMP compliance inspection, and is currently waiting for the Zhejiang Provincial Food and Drug Administration to announce the results of the GMP compliance inspection for this variety


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.